18F-FDG imaging: pitfalls and artifacts
…, ES Crawford, HA Nabi - Journal of nuclear …, 2005 - Soc Nuclear Med
18 F-FDG PET is emerging as a useful tool in the staging and restaging of many malignant
neoplasms, such as lymphoma, lung cancer, colorectal cancer, head and neck cancer, breast …
neoplasms, such as lymphoma, lung cancer, colorectal cancer, head and neck cancer, breast …
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody
…, GA Wiseman, CS Marcus, HA Nabi… - Journal of nuclear …, 2002 - Soc Nuclear Med
90 Y-ibritumomab tiuxetan is a novel radioimmunotherapeutic agent recently approved for
the treatment of relapsed or refractory low-grade, follicular, or CD20+ transformed non-…
the treatment of relapsed or refractory low-grade, follicular, or CD20+ transformed non-…
Gated myocardial perfusion SPECT: basic principles, technical aspects, and clinical applications
AK Paul, HA Nabi - Journal of nuclear medicine technology, 2004 - Soc Nuclear Med
Electrocardiographically gated myocardial perfusion SPECT (GSPECT) is a state-of-the-art
technique for the combined evaluation of myocardial perfusion and left ventricular function …
technique for the combined evaluation of myocardial perfusion and left ventricular function …
Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible “see and treat” approach
…, J Morgan, I Charamisinau, HA Nabi… - Journal of medicinal …, 2005 - ACS Publications
Methyl 3-(1‘-m-iodobenzyloxyethyl)-3-devinylpyropheophorbide-a (2), obtained in a sequence
of reactions from pyropheophorbide-a (a chlorophyll-a derivative), was found to be a …
of reactions from pyropheophorbide-a (a chlorophyll-a derivative), was found to be a …
Clinical applications of 18F-FDG in oncology
HA Nabi, JM Zubeldia - Journal of nuclear medicine technology, 2002 - Soc Nuclear Med
PET has emerged as a powerful diagnostic tool for the evaluation of cancer patients. Currently,
most of these studies are performed with the glucose analog 18 F-FDG, which has been …
most of these studies are performed with the glucose analog 18 F-FDG, which has been …
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
H Abdel-Nabi, RJ Doerr, DM Lamonica, VR Cronin… - Radiology, 1998 - pubs.rsna.org
PURPOSE: To evaluate the diagnostic usefulness of positron emission tomography (PET)
with fluorine-18 fluorodeoxyglucose (FDG) in patients with primary colorectal carcinomas. …
with fluorine-18 fluorodeoxyglucose (FDG) in patients with primary colorectal carcinomas. …
TSPO 18 kDa (PBR) targeted photosensitizers for cancer imaging (PET) and PDT
…, M Sajjad, Y Wang, C Batt, HA Nabi… - ACS Medicinal …, 2011 - ACS Publications
Translocator protein (TSPO) 18 kDa overexpression has been observed in a large variety of
human cancers, especially breast cancers. PK 11195, an isoquinoline analogue, is one of …
human cancers, especially breast cancers. PK 11195, an isoquinoline analogue, is one of …
Breast cancer imaging with radiolabeled antibodies
DM Goldenberg, HA Nabi - Seminars in nuclear medicine, 1999 - Elsevier
Over the past 2 decades, numerous anticancer antibodies against different molecular targets
and labeled with different gamma-emitting radionuclides have been studied in human …
and labeled with different gamma-emitting radionuclides have been studied in human …
[HTML][HTML] Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
M Khalaf, H Abdel-Nabi, J Baker, Y Shao… - Journal of hematology & …, 2008 - Springer
Abstract The most common semiquantitative method of evaluation of pulmonary lesions using
18 F-FDG PET is FDG standardized uptake value (SUV). An SUV cutoff of 2.5 or greater …
18 F-FDG PET is FDG standardized uptake value (SUV). An SUV cutoff of 2.5 or greater …
Compared to Purpurinimides, the Pyropheophorbide Containing an Iodobenzyl Group Showed Enhanced PDT Efficacy and Tumor Imaging (124I-PET) Ability
…, JR Missert, C Batt, R Yao, HA Nabi… - Bioconjugate …, 2009 - ACS Publications
Two positional isomers of purpurinimide, 3-[1′-(3-iodobenzyloxyethyl)] purpurin-18-N-hexylimide
methyl ester 4, in which the iodobenzyl group is present at the top half of the molecule …
methyl ester 4, in which the iodobenzyl group is present at the top half of the molecule …